SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001562762-15-000133
Filing Date
2015-05-08
Accepted
2015-05-08 16:31:50
Documents
11
Period of Report
2015-03-31
Filing Date Changed
2015-05-08

Document Format Files

Seq Description Document Type Size
1 10-Q cort-20150331x10q.htm 10-Q 854384
2 EX-31.1 cort-20150331xex311.htm EX-31.1 17260
3 EX-31.2 cort-20150331xex312.htm EX-31.2 17703
4 EX-32.1 cort-20150331xex321.htm EX-32.1 9583
5 EX-32.2 cort-20150331xex322.htm EX-32.2 9882
  Complete submission text file 0001562762-15-000133.txt   3220859

Data Files

Seq Description Document Type Size
6 EX-101.INS cort-20150331.xml EX-101.INS 373028
7 EX-101.SCH cort-20150331.xsd EX-101.SCH 19184
8 EX-101.CAL cort-20150331_cal.xml EX-101.CAL 33006
9 EX-101.DEF cort-20150331_def.xml EX-101.DEF 37982
10 EX-101.LAB cort-20150331_lab.xml EX-101.LAB 151472
11 EX-101.PRE cort-20150331_pre.xml EX-101.PRE 121031
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 15847261
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1